Qube Research & Technologies Ltd - HUTCHISON CHINA MEDITECH LTD ownership

HUTCHISON CHINA MEDITECH LTD's ticker is HCM and the CUSIP is 44842L103. A total of 83 filers reported holding HUTCHISON CHINA MEDITECH LTD in Q4 2022. The put-call ratio across all filers is 29.57 and the average weighting 0.2%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of HUTCHISON CHINA MEDITECH LTD
ValueSharesWeighting
Q4 2022$1,249,280
+185.9%
84,525
+144.3%
0.01%
+133.3%
Q2 2022$437,000
-64.2%
34,598
-46.5%
0.00%
-70.0%
Q1 2022$1,222,000
+222.4%
64,612
+382.1%
0.01%
+66.7%
Q1 2021$379,000
+9.5%
13,402
-30.9%
0.01%
-97.4%
Q3 2019$346,000
-21.4%
19,395
-3.0%
0.23%
+119.0%
Q2 2019$440,00020,0000.10%
Other shareholders
HUTCHISON CHINA MEDITECH LTD shareholders Q4 2022
NameSharesValueWeighting ↓
GENERAL ATLANTIC, L.P. 4,000,000$67,760,0001.05%
M&G INVESTMENT MANAGEMENT LTD 7,084,834$120,442,1780.54%
Bellevue Group AG 1,802,963$30,584,7610.49%
AIA Group Ltd 391,278$6,628,2490.32%
PLATINUM INVESTMENT MANAGEMENT LTD 182,052$3,083,9610.12%
SCHRODER INVESTMENT MANAGEMENT GROUP 4,219,168$71,472,7060.11%
Hennion & Walsh Asset Management, Inc. 51,735$876,3910.06%
Allianz Asset Management GmbH 1,644,999$27,866,2830.05%
Janney Capital Management LLC 17,203$2910.02%
ACADIAN ASSET MANAGEMENT LLC 193,811$3,2680.01%
View complete list of HUTCHISON CHINA MEDITECH LTD shareholders